NICE Updates UK Guidelines for Lokelma in CKD-HK
The National Institute of Health and Care Excellence (NICE) has updated its guideline for AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) in…
By
Approvals
Latest in
Approvals
FDA expands approval for AbbVie’s Skyrizi for active psoriatic arthritis
The FDA approval is based on data from two Skyrizi Phase III trials, KEEPsAKE-1 and KEEPsAKE-2.
Gilead’s Veklury obtains FDA approval to treat Covid-19 outpatients
The authorised dosage is daily intravenous doses of Veklury to be administered for three consecutive days.
KRAS G12C inhibitors in NSCLC forecast to achieve over $1bn in sales by 2024
GlobalData estimates that Amgen’s Lumakras (sotorasib) is set to become a blockbuster agent in non-small cell lung cancer.
By
Bristol-Myers Squibb’s Abecma gets approval in Japan for multiple myeloma
The approval for Abecma is based on data obtained from the Phase II Study BB2121-MM-001 and the Phase I Study…
US FDA clears Nuvation Bio’s application for solid tumour therapy
The company will start a trial of NUV-868 as a single agent and along with olaparib or enzalutamide in solid…
Japan approves Pfizer-BioNTech’s Covid-19 vaccine for children
The vaccine doses that will be administered for children will use one-third of a dose given for adults.
FDA approves Janus kinase inhibitors Rinvoq and Cibinqo despite safety concerns
The introduction of Rinvoq and Cibinqo to the atopic dermatitis market will provide more treatment options for many patients.
By